Assembly Biosciences

IPO

Home - Assembly Bio

Public · South San Francisco, United States · Founded 2012 · $217.7M raised

Employees
51–200
Founded
2012
Business Model
B2B
Total Funding
$217.7M
Last Round
$175.0M Venture RoundAug 2025
Rounds
3
Type
Public

About

Assembly Biosciences is a clinical-stage biotechnology company dedicated to developing innovative small-molecule antiviral therapeutics targeting serious viral diseases. The company's pipeline focuses on recurrent genital herpes, chronic hepatitis delta virus (HDV), and chronic hepatitis B (HBV). Assembly Bio partners with Gilead Sciences to advance novel antiviral treatments with the potential to change disease outcomes for patients worldwide.

Summary

Assembly Biosciences is a Biotech company based in South San Francisco, United States, founded in 2012. It has raised $217.7M in total across 3 rounds, most recently a $175.0M Venture Round round in Aug 2025. Investors include Gilead Sciences, Armistice Capital and Commodore Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2025
$175.0M

Sign up to see all 3 rounds

Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Assembly Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/assembly-biosciences"><img src="https://indexed.vc/api/badge/company/assembly-biosciences" alt="Assembly Biosciences on Indexed.vc" width="260" height="76" /></a>